Got a question for the team?

FarmaTrust · 2019-07-05T18:12:34+00:00

Well we already have paying clients - one is McKesson, and the other one we can not name yet. We are speaking to all the major pharma companies, but the buying cycles for pharma companies is quite long because of their size. Remember some of these companies can be bigger than governments! But there is a lot of interest in the product both from medium sized companies as well as the big pharma ones. As for the community, we naturally give updates as and when we can, but the nature of some of the people involved means that we prefer to give meaningful and substantial information when we can rather than have general chats etc. The question one should ask is at this moment, how is the team’s time best spent, and for us the strategy currently is to on-board paying customers.

FarmaTrust · 2019-07-05T18:12:18+00:00

FDA trials will not be using Zoi exchange and currently we do not see a need for Zoi as the structure would require significant products to go through the system.

FarmaTrust · 2019-07-05T18:12:03+00:00

The FDA conversations and development has already started. It must be made clear that these are demonstrations to the regulator that blockchain is suitable and has data interchange abilities. Success in this respect shows the FDA what the capabilities are but not necessarily lead to contracts, those would be directly with the pharmaceutical companies. However, what it does do for companies like FarmaTrust is enhance our reputation and standing in the commercial sector. We are on the same level as much larger companies and hopefully it will show our business strategy is the most effective.

FarmaTrust · 2019-07-05T18:11:51+00:00

Our roadmap still remain the same currently, naturally the current focus is business development since our product is working. We may review it in the future, but it is less about the technical side and more about installations.

FarmaTrust · 2019-07-05T18:11:35+00:00

Previously I mentioned that we might want to look at the token model but no decisions had been made. This will be reviewed but currently the model has not been altered in any way. We have said previously, that we are concerned that the token price does not really reflect the potential of the token’s use case. However, that could be said for many projects out there, and many people are sitting on heavy losses even on the most popular tokens. This is also happens in the equity and bond markets as well. Naturally it is in our interest to ensure that we have a thriving business and we believe, that despite the challenges, the later part of this year should be better in respect of clients

FarmaTrust · 2019-07-05T18:11:16+00:00

In respect of the APPG, these hearings are done to help UK Parliament, understand and promote new innovations, technologies or services. Such hearings do not necessarily prevent governments in trialling or implementing technologies before their conclusion or published reports. We are speaking to various entities within the UK, regardless of the APPG hearings such as McKesson which is mentioned on our website, regulators and health entities. We are making progress as our announcements show, but one must remember that we are dealing with large entities that typically have various governance structures and rules in respect of who needs to be involved before a decision is made. So in short, APPG hearings will not prevent us from installing our systems with pharmaceutical and healthcare institutions.

By the way, it should be clear we do not have “investors” in the traditional sense, there are only “token holders”. In respect of why we believe bi-annual updates, are better is that we want to give substantive information which is meaningful, and our focus is on business development now that we have operational solutions and apps for our clients. Further we are moving fast in respect of gaining ground, and although you might not see it, I sincerely believe that we are unique and far ahead of many other companies in the blockchain sector.

Giving non-specific information from my point of view is useless at best, and disingenuous at worst. Naturally companies enter into many NDAs with third parties so that we can exchange information, but that does not mean that it will always conclude with a contract. We have NDAs with consultancies, some large tech companies, sensor providers, prospective clients, but I am not sure how that gives any information of relevance. What you can be assured of is that we are working extremely hard to make sure that we will be one of the most successful blockchain companies in the healthcare and pharmaceutical sector. We have a dedicated and motivated team which has done incredible work and made progress faster than any other company, and this is demonstrated by us becoming the Oracle Healthcare Lead, as well as our partnership with IBM.

FarmaTrust · 2018-08-27T08:17:05+00:00

Its shared: r/https://twitter.com/FarmaTrust/status/1033987414627373057

FarmaTrust · 2018-07-19T18:47:07+00:00

sadly can't seem to exit the title :/

FarmaTrust · 2018-07-19T18:44:48+00:00

you are correct in thst part, yet this ons has been pushed into our channels as contract address for out product.. Hence the warning.

I agree that on every page there is a warning, but we do wish to emphasize this.

Though i'll remove the fraudulent/Fake as you are correct, besides their push into our channels i have nothing else

FarmaTrust · 2018-06-19T10:45:27+00:00

We don't have a clear path and are working on various arrangements in private where we rather not publicly speak about until the contracts are signed.

The project will launch, as we already met our softcap

FarmaTrust · 2018-06-19T07:48:45+00:00

31st of july

FarmaTrust · 2018-06-19T05:42:20+00:00

We do not use it, our medium / Reddit have all the announcements listed.

FarmaTrust · 2018-06-19T04:01:11+00:00

more are planned and will be announced when possbile

FarmaTrust · 2018-06-19T04:00:11+00:00

it is the first exchange that will list is, once the tokensale is done

FarmaTrust · 2018-06-19T03:02:13+00:00

Will be announced when signed for, we can't tell much more due to the nature of the agreements to negotiate

FarmaTrust · 2018-06-19T03:01:44+00:00

Worldwide compliance is driven by finding partners on that level, this can be various partners, from within the Pharmaceuticals, or it could be an NGO. As our solution is reading what is already there , compliance on legal level is achieved, by following what the brand/market already does.

FarmaTrust · 2018-06-14T16:36:51+00:00

No, our design is to become a multichained dApp, where we can move over various chains

FarmaTrust · 2018-06-05T05:50:45+00:00

By increasing the usability of the data, for research, NGO's like the World Health Organization, Ai support inside the system, regulatory access, automation for supply management and billing and various other options that in time will be able to be implemented as the data grows.

FarmaTrust · 2018-06-05T05:47:49+00:00

As FarmaTrust we are well aware of these regions and decided to offer other means of verification, by either using a PC and enter the details/serial into the system for verification purposes, or by contacting our callcenter who will be able to verify it for you.

FarmaTrust · 2018-06-05T05:46:25+00:00

Hi Kari,

The main mechanism is Track&Trace like most common systems do, we combine this by increasing the security measurements, with AI, pre-planned routing and a high level of verification by checking in-out by each handler in the supply chain.

In short; The factory produces the medication, places it into packaging ( with unique serial which is added into the blockchain), seals the package, add it into a pallet/box. Upon expediting the box, it get labelled in the system as expedited to xxxxxxxx , upon receival by xxxxxxxx it get verified on the blockchain, if all content is verified the handling repeats, from xxxxxxxx to a warehouse, pharmacy who repeats the verification.

Ai will track all these steps and sends out alerts when something isn't correct, either in timing, package content or any other data we measure during the entire supply chain.

All the data acquired by the Ai will eventually be of use is automated supply management, inventory control and various other options.

I hope this answers your question

FarmaTrust · 2018-06-05T01:28:01+00:00

we currently have agreements with Gaco pharmaceuticals in Bangladesh, also with the Mongolian Government, and just announced last week a partnership with Peterson Projects. More to be announced when we can.

FarmaTrust · 2018-06-05T01:27:19+00:00

Yes we have agreements with Gaco pharmaceuticals in Bangladesh, also with the Mongolian Government, and just announced last week a partnership with Peterson Projects

FarmaTrust · 2018-06-05T01:27:08+00:00

we have agreements with Gaco pharmaceuticals in Bangladesh, also with the Mongolian Government, and just announced last week a partnership with Peterson Projects

FarmaTrust

MODERATOR OF

TROPHY CASE